Navigation Links
Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD
Date:5/20/2008

Data Presented at the 2008 International Conference of the American

Thoracic Society

TORONTO, May 20 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. and Laboratorios Almirall, S.A. today presented results from four clinical trials assessing the efficacy and safety of aclidinium bromide, an investigational treatment for chronic obstructive pulmonary disease (COPD). Data from four preclinical studies further describing the properties of aclidinium were also presented at the meeting.

(Logo: http://www.newscom.com/cgi-bin/prnh/20001011/FORESTLOGO )

Presentations included data from a 464-patient randomized, double-blind, four-week, Phase IIb study that evaluated both the efficacy and tolerability of once-daily aclidinium (25 mcg, 50 mcg, 100 mcg, 200 mcg or 400 mcg) or placebo in patients with moderate to severe COPD. An open-label tiotropium (18 mcg) arm was included as an active control. The study demonstrated aclidinium (200 mcg and 400 mcg), administered via a multi-dose dry powder inhaler, significantly increased trough (24-hour) forced expiratory volume in one second (FEV1) -- an important measure of lung function -- on Day 29 compared with placebo (p<0.05 vs placebo). There was a dose response observed for lung function improvement with once-daily aclidinium. Aclidinium was well tolerated, with no dose-dependent effect on ECG, laboratory parameters, or adverse events. Overall, the most frequently reported adverse events were headache (4.1% of patients), dry mouth (2.8% of patients), exacerbation of chronic obstructive airways disease (1.7% of patients) and cough (1.7% of patients). Based on these results, aclidinium 200 mcg administered once every 24 hours was selected as the dose for investigation in the two ongoing Phase III clinical trials, ACCLAIM COPD I and II, which are expected to report out during the second ha
'/>"/>

SOURCE Forest Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Microbia and Forest Laboratories Announce Preliminary Results of Linaclotide Phase 2b Studies
2. Forest Laboratories, Inc. Announces Positive Results of LEXAPRO(R) Phase III Study in Adolescents With Major Depression
3. Forest Laboratories, Inc. and Gedeon Richter Announce Results of Phase II-B Study for RGH-188 as a Treatment for Schizophrenia
4. Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)
5. Fuisz Tobacco Announces Clinical Study Results for Fuisz Tobacco Sheet Strip; Super Enhanced Bioavailability of Nicotine From Its Tobacco Sheet Strip Supports Efficacy of Low Dose Tobacco Product
6. InterMune Announces Receipt of Fast Track Designation for Pirfenidone From FDA
7. Ipsogen Announces Three Studies at the American Society of Clinical Oncology (ASCO) Meeting Extending the Utility of the Genomic Grade Index for Predicting Response to Chemotherapy in Breast Cancer
8. TAP Pharmaceutical Products Inc. Announces Phase 3 TAK-390MR Data Demonstrating Higher Overall Healing Versus Lansoprazole in Patients with Erosive Esophagitis
9. Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials
10. GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab)
11. ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... 24, 2015 Introduction ... indication-specific planning tools for radiosurgery/SBRT   ... aimed at enhancing the workflow for difficult to ... in 2013 - comes full circle with the ... These new Elements enable on-the-fly generation of consistent ...
(Date:4/24/2015)... , April 24, 2015 Hi-Tech ... that such was not the product of reliable scientific ... a reliable basis for allegations of adulteration. The ... on a false premise, or misguided hope, that ... these studies are contradicted by multiple other studies ...
(Date:4/24/2015)... Hospira, Inc. (NYSE: HSP ... therapies, spoke about the importance of extrapolation in bringing ... (EGA) annual European Biosimilars Group conference in ... the publication of a pivotal white paper titled, ... of biosimilars." Speaking at the EGA ...
Breaking Medicine Technology:Brainlab Introduces New Generation of VMAT* for Brain and Spine at 3rd ESTRO in Barcelona 2Hi-Tech Responds to "Bullying Tactics" Issued by FDA on Acacia Rigidula 2Hi-Tech Responds to "Bullying Tactics" Issued by FDA on Acacia Rigidula 3Hi-Tech Responds to "Bullying Tactics" Issued by FDA on Acacia Rigidula 4Hi-Tech Responds to "Bullying Tactics" Issued by FDA on Acacia Rigidula 5Hi-Tech Responds to "Bullying Tactics" Issued by FDA on Acacia Rigidula 6Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 2Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 3Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 4Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 5Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 6Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 7
... January 5, 2012 Orthopedic Implants are medical ... injured or troubled joints. Bone is the basic element of ... and assists in movement. Humans commonly suffer from physical fractures, ... or humerus. Treatment of these fractures often requires surgery to ...
... SAN DIEGO, Jan. 5, 2012 Cardium Therapeutics (NYSE Amex: ... entered into its first international agreement for the commercialization ... Cardium entered into a marketing and distribution agreement with ... Korea, for the commercialization of Excellagen Formulated Fibrillar Collagen ...
Cached Medicine Technology:Narang Medical Introduces NET Multifix Nails: Same Nail That Can be Used for Right and Left Legs 2Cardium Announces First International Marketing and Distribution Agreement for Commercialization of Excellagen™ in South Korea 2Cardium Announces First International Marketing and Distribution Agreement for Commercialization of Excellagen™ in South Korea 3Cardium Announces First International Marketing and Distribution Agreement for Commercialization of Excellagen™ in South Korea 4Cardium Announces First International Marketing and Distribution Agreement for Commercialization of Excellagen™ in South Korea 5Cardium Announces First International Marketing and Distribution Agreement for Commercialization of Excellagen™ in South Korea 6
(Date:4/26/2015)... India Network Foundation, a non-profit organization in the ... the Asian Indian community in the United States and ... two decades. The India News Network Digest of 1990s ... world with the latest news items from India, the ... Forum Digest, edited and contributed by Sheela Murthy, helped ...
(Date:4/26/2015)... Petersburg, FL (PRWEB) April 26, 2015 ... Diego, California. The city is one which is synonymous with ... Tourism, international trade, and education are major economic influencers in ... Producers of the dynamic talk show are pleased to announce ... on Sunday, April 26 at 3:00 PM PDT. Tune in ...
(Date:4/25/2015)... The National League for Nursing's Advancing Care ... prepare nurses to provide high quality, culturally sensitive care ... a new report by the John A. Hartford Foundation, ... The project began in 2007 as a pilot at ... Elaine Tagliareni, EdD, RN, CNE, FAAN, professor and Independence ...
(Date:4/25/2015)... In observance of World Malaria Day, today ... Pledge, a two-year pledge by the United Nations Foundation’s ... one million bednets by 2016. This ambitious $10 million ... to protect children, refugees, and families displaced by conflict ... been a large surge in refugee families displaced by ...
(Date:4/25/2015)... York, New York (PRWEB) April 25, 2015 ... ) established for vaginal mesh lawsuits filed against ... the U.S. District Court, Southern District of West ... 9th, a Scheduling Conference was convened that day, ... Plaintiffs’ Master Long Form Complaint. The Order directed ...
Breaking Medicine News(10 mins):Health News:North American Telugu Society Bestows Community Service Award to India Network Foundation for Its Generosity and Sponsor of Visitor Health Insurance to Indian Visitors 2Health News:North American Telugu Society Bestows Community Service Award to India Network Foundation for Its Generosity and Sponsor of Visitor Health Insurance to Indian Visitors 3Health News:Forbes Living TV Will Air in San Diego, California 2Health News:Hartford Foundation Report Details Success of NLN's Advancing Care Excellence for Seniors (ACE.S) Program 2Health News:Hartford Foundation Report Details Success of NLN's Advancing Care Excellence for Seniors (ACE.S) Program 3Health News:Supporters Worldwide Join The Million Nets Pledge on World Malaria Day 2Health News:Supporters Worldwide Join The Million Nets Pledge on World Malaria Day 3Health News:Supporters Worldwide Join The Million Nets Pledge on World Malaria Day 4Health News:C.R. Bard Vaginal Mesh Lawsuit News: Federal Litigation Issues New Pretrial Order Following Submission of Amended Responses to Master Complaint 2Health News:C.R. Bard Vaginal Mesh Lawsuit News: Federal Litigation Issues New Pretrial Order Following Submission of Amended Responses to Master Complaint 3Health News:C.R. Bard Vaginal Mesh Lawsuit News: Federal Litigation Issues New Pretrial Order Following Submission of Amended Responses to Master Complaint 4
... Health Common User Interface will help, increase clinician efficiency ... ... Wash., Sept. 10 Healthcare,developers will be able to increase ... User Interface (CUI),available today from Microsoft Corp. The guidance and ...
... School of Medicine have developed a molecular probe that ... is to use the probe to improve the diagnosis ... probe,s main ingredient is a molecule that labels active ... cancerous cells. The molecule is normally invisible to the ...
... PAINWeek 2007 Said Most Patients ... VEGAS, Sept. 8 In addition to reporting a ... surveyed,during PAINWeek 2007 said treating pain will improve insomnia ... Nearly 98 percent of those polled said they believed ...
... Sets Better Ability to Improve Patient Care, ... St.,Francis Medical Center have reached a tentative agreement ... that will increase their ability to,advocate for improved ... of a qualified and skilled staff. The ...
... 2007 Inc. 500, LAS VEGAS, Sept. 7 Inc. ... Inc. 500 list of the fastest-growing,private companies in the U.S. ... that same category, achieved a record three year sales growth ... "If you want to find out which companies are going ...
... VNUS(R) Medical,Technologies, Inc. (Nasdaq: VNUS ), a ... treatment of venous reflux disease, today,announced the resignation ... President, Finance & Administration, to be effective October ... begun a search for a,new chief financial officer. ...
Cached Medicine News:Health News:Microsoft Helps Developers of Clinical User Interfaces Improve Efficiency, Patient Safety With Free Toolkit 2Health News:Microsoft Helps Developers of Clinical User Interfaces Improve Efficiency, Patient Safety With Free Toolkit 3Health News:Microsoft Helps Developers of Clinical User Interfaces Improve Efficiency, Patient Safety With Free Toolkit 4Health News:Molecular probe 'paints' cancer cells in living animals, Stanford researchers find 2Health News:Molecular probe 'paints' cancer cells in living animals, Stanford researchers find 3Health News:Link Between Chronic Pain and Insomnia Uncovered at PAINWeek 2007 2Health News:Link Between Chronic Pain and Insomnia Uncovered at PAINWeek 2007 3Health News:Workers Win Contract at St. Francis Medical Center 2Health News:Inc. Magazine Reveals Its 26th Annual List of America's 500 Fastest-Growing Private Companies 2Health News:Inc. Magazine Reveals Its 26th Annual List of America's 500 Fastest-Growing Private Companies 3
... The Chalam Flat is ... nerve neurotomy and induction of ... also useful for macula whole ... removal of tractional epiretinal membranes. ...
... 1.5x is specifically designed ... peeling in macular hole ... sheathotomy and macularepiretinal membrane ... and other situations warranting ...
... ACS lenses offer the high resolution, high ... original clariVits. The simple two part design ... integrity during surgery. Simply autoclave, add saline ... lock together for use. (ACS) AutoClave Sterilizable ...
... offers high resolution by far surpassing ... in stereopsis, brilliance and clarity, detailed ... in diabetics, membrane peeling extending to ... Sterilizable Lenses The ACS Vitrectomy Lenses ...
Medicine Products: